EXTX.OL

Healthcare Biotechnology

EXACT Therapeutics AS

NOK 0.50

-0.00 -0.40% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 8, 2026, live at 11:02 AM ET	0.50

Key Stats

Market Cap

55.55M

Avg Volume

47,954

EPS

-NOK 0.93

52W High

NOK 2.70

52W Low

NOK 0.45

Div. Yield

0.0%

Valuation

P/B Ratio

0.48

P/S Ratio

712.17

EV/EBITDA

0.25

EV/Revenue

-239.40

Margins

Gross Margin 100.0%

Operating Margin (199799.2%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(113.5%)

Return on Assets

(51.6%)

Liquidity & Leverage

Current Ratio

4.16

Quick Ratio

3.09

Debt / Equity

0.00

Total Cash

49.10M

Total Debt

63,063

About

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy. The company's ACT platform is under Phase 2 clinical trial for the treatment of pancreatic disease; Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. It has a collaboration with GE Healthcare. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.

exact-tx.com